These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26800696)

  • 1. Levetiracetam Pharmacokinetics During Continuous Venovenous Hemofiltration and Acute Liver Dysfunction.
    New AM; Nei SD; Kashani KB; Rabinstein AA; Frazee EN
    Neurocrit Care; 2016 Aug; 25(1):141-4. PubMed ID: 26800696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.
    Nei SD; Wittwer ED; Kashani KB; Frazee EN
    Pharmacotherapy; 2015 Aug; 35(8):e127-30. PubMed ID: 26242293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
    Van Matre ET; Mueller SW; Fish DN; MacLaren R; Cava LF; Neumann RT; Kiser TH
    Am J Case Rep; 2017 Apr; 18():458-462. PubMed ID: 28446744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin removal by continuous venovenous hemofiltration.
    Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
    Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration.
    Franquiz MJ; Kalaria SN; Armahizer MJ; Gopalakrishnan M; McCarthy PJ; Badjatia N
    Pharmacotherapy; 2018 Feb; 38(2):e17-e21. PubMed ID: 29160945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam Pharmacokinetics in a Critically Ill Anephric Patient on Intermittent Hemodialysis.
    Wieruszewski PM; Kashani KB; Rabinstein AA; Frazee E
    Neurocrit Care; 2018 Apr; 28(2):243-246. PubMed ID: 28828726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
    Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
    Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal Clearance of Levetiracetam During Continuous Venovenous Hemofiltration in a Critically Ill Patient and New Dosing Recommendation.
    le Noble JL; Foudraine NA; Kornips FH; van Dam DG; Neef C; Janssen PK
    J Clin Pharmacol; 2017 Apr; 57(4):536-537. PubMed ID: 27868207
    [No Abstract]   [Full Text] [Related]  

  • 10. Lacosamide Pharmacokinetics in a Critically Ill Patient During Continuous Renal Replacement Therapy.
    Wieruszewski PM; Lopez-Ruiz A; Albright RC; Fugate JE; Barreto EF
    J Pharm Pract; 2020 Jun; 33(3):395-398. PubMed ID: 30336720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
    Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01).
    Kalaria SN; Armahizer M; McCarthy P; Badjatia N; Gobburu JV; Gopalakrishnan M
    Clin Transl Sci; 2020 Sep; 13(5):950-959. PubMed ID: 32223067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentobarbital Removal During Continuous Venovenous Hemofiltration: Case Report and Review of the Literature.
    Hensler DM; McConnell DP; Levasseur-Franklin KE; Greathouse KM
    J Pharm Pract; 2018 Dec; 31(6):682-686. PubMed ID: 29162023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A missed opportunity - consequences of unknown levetiracepam pharmacokinetics in a peritoneal dialysis patient.
    Bahte SK; Hiss M; Lichtinghagen R; Kielstein JT
    BMC Nephrol; 2014 Apr; 15():49. PubMed ID: 24739070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of levetiracetam.
    Patsalos PN
    Clin Pharmacokinet; 2004; 43(11):707-24. PubMed ID: 15301575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of vancomycin in continuous veno-venous hemofiltration].
    Gu Q; Zhu ZH; Ge M; Ge WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):114-6. PubMed ID: 12857476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.